Key result
Septic cardiomyopathy is a reversible decrease in myocardial contractility secondary to sepsis, diagnosed primarily by echocardiography, with management focusing on treating the underlying infection and achieving hemodynamic stability.
Why the study?
Sepsis-induced myocardial dysfunction, or septic cardiomyopathy, remains an avenue to be explored regarding underlying pathophysiology and definite treatment guidelines.
This review highlights that while septic cardiomyopathy is a recognized, reversible complication of sepsis diagnosable by echocardiography, specific targeted treatments beyond standard hemodynamic support remain undefined.
Echocardiography aids septic cardiomyopathy diagnosis in sepsis; leaves open targeted therapies beyond standard support.
Sepsis remains a worldwide challenge for physicians with many patients admitted to ICUs with septic shock. Septic shock management involves targeted treatment to control infections, reduce end-organ damage, and reverse the injury. Sepsis-induced myocardial dysfunction or septic cardiomyopathy remains an avenue to be explored with regard to underlying pathophysiology and definite treatment guidelines. This article has compiled various studies to explain the possible mechanisms involved in the development of septic cardiomyopathy and the existing diagnostic criteria including radiological and laboratory tests to assess septic cardiomyopathy. Furthermore, the article highlights management options currently available for physicians dealing with myocardial dysfunction secondary to sepsis.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2022) conducted a review in Septic cardiomyopathy. Septic cardiomyopathy is a reversible decrease in myocardial contractility secondary to sepsis, diagnosed primarily by echocardiography, with management focusing on treating the underlying infection and achieving hemodynamic stability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: